This Viewpoint examines the conclusions of the ProtecT randomized clinical trial and argues that, instead of radical therapy, appropriate patients for active surveillance should be chosen and active surveillance strategies optimized to avoid the small increased risk of distant metastasis seen in ProtecT.
from Cancer via ola Kala on Inoreader http://ift.tt/2ylH6cX
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου